Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 9-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With Attention Deficit/Hyperactivity Disorder

NCT00315276 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00315276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 9-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With Attention Deficit/Hyperactivity Disorder
Lead sponsor
Cephalon
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
January 31, 2007
Enrollment
370
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, attention deficit hyperactivity disorder